[1]
J. Alam, S. A. Panezai, U. Shaikh, L. Kumari, Muhammad Ilyas, and S. U. kakar, “Impact of Infections in Patients with Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax during Induction Chemotherapy”, IJBR, vol. 3, no. 1, pp. 190–196, Jan. 2025.